Case Study: Reducing the Environmental Impact of Pharmaceutical Advisory Boards
folder_openCustomer Stories, Improve Your Advisory Boards
The Problem With in-person meetings resuming after the end of COVID-19-related restrictions, many of our clients have been eager to get back to these meetings, thinking that’s what their Key Opinion Leaders (KOLs) want. Traditionally, external pharmaceutical meetings such as national advisory boards are held at upscale…